SUBSEQUENT EVENTS (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Aug. 09, 2016 |
Jun. 30, 2016 |
Aug. 08, 2016 |
|
Subsequent Event | |||
Subsequent Event [Line Items] | |||
Lenders percentage of of principal held required to approve amendment | 50.00% | ||
Pharming Group N.V., North American Commercialization Rights to Ruconest | |||
Subsequent Event [Line Items] | |||
Impairment loss | $ 199 | ||
Pharming Group N.V., North American Commercialization Rights to Ruconest | Subsequent Event | |||
Subsequent Event [Line Items] | |||
Upfront purchase price | $ 125 | ||
Upfront fee | 60 | ||
Sales based milestone payments receivable (up to) | $ 65 |